Thyroid Function Alteration in Obesity and the Effect of Bariatric Surgery

Overview

Journal J Clin Med

Specialty General Medicine

Date 2022 Mar 10

PMID 35268429

Authors

Maria Cordido

Paula Juiz-Valina

Paula Urones

Susana Sangiao-Alvarellos

Fernando Cordido

Affiliations

Soon will be listed here.

Abstract

The most common endocrine disease in obesity is hypothyroidism and secondary endocrine alterations, including abnormal thyroid function, are frequent in obesity. It is unclear whether impaired thyroid function is the cause or the consequence of increased adiposity; furthermore, there are no clear data regarding the best way to dose levothyroxine for patients with both hypothyroidism and obesity, and the effect of bariatric surgery (BS). The aim of the present article is to review some controversial aspects of the relation between obesity and the thyroid: (1) Thyroid function in obesity and the effect of BS (2) Thyroid hormone treatment (THT) in obese patients with hypothyroidism and the effect of BS. In summary: In morbidly obese patients, TSH is moderately increased. Morbid obesity has a mild central resistance to the thyroid hormone, reversible with weight loss. In morbidly obese hypothyroid patients, following weight loss, the levothyroxine dose/kg of ideal weight did not change, albeit there was an increment in the levothyroxine dose/kg of actual weight. From a clinical practice perspective, in morbid obesity, diagnosing mild hypothyroidism is difficult, BS improves the altered thyroid function and THT can be adapted better if it is based on ideal weight.

Citing Articles

Effect of Laparoscopic Sleeve Gastrectomy on Hypothyroidism in Patients with Morbid Obesity: A one-year follow-up Prospective Cohort Study.

Malekpour Alamdari N, Ansari I, Azizi Nadian M, Seyyedi M, Abbasi M Iran J Pathol. 2025; 20(1):133-137.

PMID: 40060233 PMC: 11887640. DOI: 10.30699/ijp.2024.2026732.3290.

When Should the Treatment of Obesity in Thyroid Disease Begin?.

Sutkowska E, Kisiel M, Zubkiewicz-Kucharska A Biomedicines. 2025; 13(1).

PMID: 39857741 PMC: 11760466. DOI: 10.3390/biomedicines13010157.

Impaired Sensitivity to Thyroid Hormones is Associated with Central Obesity in Euthyroid Type 2 Diabetes Mellitus Patients with Overweight and Obesity.

Chen F, Chen R, Zhou J, Xu W, Zhou J, Chen X Diabetes Metab Syndr Obes. 2024; 17:3379-3396.

PMID: 39280173 PMC: 11402367. DOI: 10.2147/DMSO.S472550.

Total weight loss induces the alteration in thyroid function after bariatric surgery.

Tian Z, Nie Y, Li Z, Wang P, Zhang N, Hei X Front Endocrinol (Lausanne). 2024; 15:1333033.

PMID: 38352711 PMC: 10861714. DOI: 10.3389/fendo.2024.1333033.

Causal association between obesity and hypothyroidism: a two-sample bidirectional Mendelian randomization study.

Qiu Y, Liu Q, Luo Y, Chen J, Zheng Q, Xie Y Front Endocrinol (Lausanne). 2024; 14:1287463.

PMID: 38260160 PMC: 10801094. DOI: 10.3389/fendo.2023.1287463.

References

Crujeiras A, Goyenechea E, Abete I, Lage M, Carreira M, Martinez J . Weight regain after a diet-induced loss is predicted by higher baseline leptin and lower ghrelin plasma levels. J Clin Endocrinol Metab. 2010; 95(11):5037-44. DOI: 10.1210/jc.2009-2566. View

Pasquali R, Casanueva F, Haluzik M, van Hulsteijn L, Ledoux S, Monteiro M . European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity. Eur J Endocrinol. 2019; 182(1):G1-G32. DOI: 10.1530/EJE-19-0893. View

Neves J, Oliveira S, Souteiro P, Pedro J, Magalhaes D, Guerreiro V . Effect of Weight Loss after Bariatric Surgery on Thyroid-Stimulating Hormone Levels in Patients with Morbid Obesity and Normal Thyroid Function. Obes Surg. 2017; 28(1):97-103. DOI: 10.1007/s11695-017-2792-5. View

Juiz-Valina P, Cordido M, Outeirino-Blanco E, Pertega S, Varela-Rodriguez B, Garcia-Brao M . Central Resistance to Thyroid Hormones in Morbidly Obese Subjects Is Reversed after Bariatric Surgery-Induced Weight Loss. J Clin Med. 2020; 9(2). PMC: 7073690. DOI: 10.3390/jcm9020359. View

Hogild M, Bak A, Pedersen S, Rungby J, Frystyk J, Moller N . Growth hormone signaling and action in obese versus lean human subjects. Am J Physiol Endocrinol Metab. 2018; 316(2):E333-E344. DOI: 10.1152/ajpendo.00431.2018. View

Michalaki M, Gkotsina M, Mamali I, Markantes G, Faltaka A, Kalfarentzos F . Impaired pharmacokinetics of levothyroxine in severely obese volunteers. Thyroid. 2011; 21(5):477-81. DOI: 10.1089/thy.2010.0149. View

Ylli D, Wartofsky L . Can We Link Thyroid Status, Energy Expenditure, and Body Composition to Management of Subclinical Thyroid Dysfunction?. J Clin Endocrinol Metab. 2018; 104(1):209-212. DOI: 10.1210/jc.2018-01997. View

Reinehr T, Andler W . Thyroid hormones before and after weight loss in obesity. Arch Dis Child. 2002; 87(4):320-3. PMC: 1763034. DOI: 10.1136/adc.87.4.320. View

Reinehr T . Obesity and thyroid function. Mol Cell Endocrinol. 2009; 316(2):165-71. DOI: 10.1016/j.mce.2009.06.005. View

10.

Zendel A, Abu-Ghanem Y, Dux J, Mor E, Zippel D, Goitein D . The Impact of Bariatric Surgery on Thyroid Function and Medication Use in Patients with Hypothyroidism. Obes Surg. 2017; 27(8):2000-2004. DOI: 10.1007/s11695-017-2616-7. View

11.

Jostel A, Ryder W, Shalet S . The use of thyroid function tests in the diagnosis of hypopituitarism: definition and evaluation of the TSH Index. Clin Endocrinol (Oxf). 2009; 71(4):529-34. DOI: 10.1111/j.1365-2265.2009.03534.x. View

12.

Julia H, Benaiges D, Molla P, Pedro-Botet J, Villatoro M, Fontane L . Changes in Thyroid Replacement Therapy after Bariatric Surgery: Differences between Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Sleeve Gastrectomy. Obes Surg. 2019; 29(8):2593-2599. DOI: 10.1007/s11695-019-03890-9. View

13.

Carlsson L, Sjoholm K, Jacobson P, Andersson-Assarsson J, Svensson P, Taube M . Life Expectancy after Bariatric Surgery in the Swedish Obese Subjects Study. N Engl J Med. 2020; 383(16):1535-1543. PMC: 7580786. DOI: 10.1056/NEJMoa2002449. View

14.

Alvarez-Castro P, Sangiao-Alvarellos S, Brandon-Sanda I, Cordido F . [Endocrine function in obesity]. Endocrinol Nutr. 2011; 58(8):422-32. DOI: 10.1016/j.endonu.2011.05.015. View

15.

Ward Z, Bleich S, Cradock A, Barrett J, Giles C, Flax C . Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity. N Engl J Med. 2019; 381(25):2440-2450. DOI: 10.1056/NEJMsa1909301. View

16.

Fallahi P, Ferrari S, Camastra S, Politti U, Ruffilli I, Vita R . TSH Normalization in Bariatric Surgery Patients After the Switch from L-Thyroxine in Tablet to an Oral Liquid Formulation. Obes Surg. 2016; 27(1):78-82. DOI: 10.1007/s11695-016-2247-4. View

17.

Rudnicki Y, Slavin M, Keidar A, Kent I, Berkovich L, Tiomkin V . The effect of bariatric surgery on hypothyroidism: Sleeve gastrectomy versus gastric bypass. Surg Obes Relat Dis. 2018; 14(9):1297-1303. DOI: 10.1016/j.soard.2018.06.008. View

18.

Cordido F, Fernandez T, Martinez T, Penalva A, Peino R, Casanueva F . Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism. J Clin Endocrinol Metab. 1998; 83(12):4350-4. DOI: 10.1210/jcem.83.12.5310. View

19.

Pena-Bello L, Seoane-Pillado T, Sangiao-Alvarellos S, Outeirino-Blanco E, Varela-Rodriguez B, Juiz-Valina P . Oral glucose-stimulated growth hormone (GH) test in adult GH deficiency patients and controls: Potential utility of a novel test. Eur J Intern Med. 2017; 44:55-61. DOI: 10.1016/j.ejim.2017.06.004. View

20.

Smith A, Henriksen B, Cohen A . Pharmacokinetic considerations in Roux-en-Y gastric bypass patients. Am J Health Syst Pharm. 2011; 68(23):2241-7. DOI: 10.2146/ajhp100630. View